The CD85J/leukocyte inhibitory receptor-1 distinguishes between conformed and β2-microglobulin-free HLA-G molecules

Journal of Immunology

Volumn 175, Issue 8, 2005, Pages 4866-4874

  Gonen Gross, Tsufit ^a   Achdout, Hagit ^a   Arnon, Tal I ^a   Gazit, Roi ^a   Stern, Noam ^a   Hořejší, Václav ^b   Goldman Wohl, Debra ^c   Yagel, Simcha ^c   Mandelboim, Ofer ^a  

^a HEBREW UNIVERSITY   (Israel)

^b INSTITUTE OF MATHEMATICS   (Czech Republic)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BETA 2 MICROGLOBULIN; CD86J ANTIGEN; CELL RECEPTOR; HLA G ANTIGEN; LEUKOCYTE INHIBITORY RECEPTOR 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CELL SURFACE; COMPLEX FORMATION; CONTROLLED STUDY; CYTOTROPHOBLAST; DECIDUA; DISULFIDE BOND; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; NATURAL KILLER CELL; PLACENTA DEVELOPMENT; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

EID: 26844481034     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.8.4866     Document Type: Article

References (66)

1. Moffett-King, A., G. Entrican, S. Ellis, J. Hutchinson, and D. Bainbridge. 2002. Natural killer cells and reproduction. Trends Immunol. 23: 332-333.
2. Hanna, J., O. Wald, D. Goldman-Wohl, D. Prus, G. Markel, R. Gazit, G. Katz, R. Haimov-Kochman, N. Fujii, S. Yagel, et al. 2003. CXCL12 expression by invasive trophoblasts induces the specific migration of CD16-human natural killer cells. Blood 102: 1569-1577.
3. Hanna, J., P. Bechtel, Y. Zhai, F. Youssef, K. McLachlan, and O. Mandelboim. 2004. Novel insights on human NK cells' immunological modalities revealed by gene expression profiling. J. Immunol. 173: 6547-6563.
4. King, A., S. E. Hiby, L. Gardner, S. Joseph, J. M. Bowen, S. Verma, T. D. Burrows, and Y. W. Loke. 2000. Recognition of trophoblast HLA class I molecules by decidual NK cell receptors: a review. Placenta 21(Suppl. A): S81-S85.
5. King, A., L. Thomas, and P. Bischof. 2000. Cell culture models of trophoblast II: trophoblast cell lines: a workshop report. Placenta 21(Suppl. A): S113-S119.
6. Trundley, A., and A. Moffett. 2004. Human uterine leukocytes and pregnancy. Tissue Antigens 63: 1-12.
7. Le Bouteiller, P., and F. Lenfant. 1996. Antigen-presenting function(s) of the non-classical HLA-E, -F and -G class I molecules: the beginning of a story. Res. Immunol. 147: 301-313.
8. McMaster, M. T., C. L. Librach, Y. Zhou, K. H. Lim, M. J. Janatpour, R. DeMars, S. Kovats, C. Damsky, and S. J. Fisher. 1995. Human placental HLA-G expression is restricted to differentiated cytotrophoblasts. J. Immunol. 154: 3771-3778.
9. King, A., D. S. Allan, M. Bowen, S. J. Powis, S. Joseph, S. Verma, S. E. Hiby, A. J. McMichael, Y. W. Loke, and V. M. Braud. 2000. HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells. Eur. J. Immunol. 30: 1623-1631.
10. Boyson, J. E., B. Rybalov, L. A. Koopman, M. Exley, S. P. Balk, F. K. Racke, F. Schatz, R. Masch, S. B. Wilson, and J. L. Strominger. 2002. CD1d and invariant NKT cells at the human maternal-fetal interface. Proc. Natl. Acad. Sci. USA 99: 13741-13746.
11. King, A., C. Boocock, A. M. Sharkey, L. Gardner, A. Beretta, A. G. Siccardi, and Y. W. Loke. 1996. Evidence for the expression of HLAA-C class I mRNA and protein by human first trimester trophoblast. J. Immunol. 156: 2068-2076.
12. Kovats, S., E. K. Main, C. Librach, M. Stubblebine, S. J. Fisher, and R. DeMars. 1990. A class I antigen, HLA-G, expressed in human trophoblasts. Science 248: 220-223.
13. van der Ven, K., K. Pfeiffer, and S. Skrablin. 2000. HLA-G polymorphisms and molecule function: questions and more questions-a review. Placenta 21(Suppl. A): S86-S92.
14. Moreau, P., P. Rousseau, N. Rouas-Freiss, M. Le Discorde, J. Dausset, and E. D. Carosella. 2002. HLA-G protein processing and transport to the cell surface. Cell. Mol. Life Sci. 59: 1460-1466.
15. Goodridge, J. P., C. S. Witt, F. T. Christiansen, and H. S. Warren. 2003. KIR2DL4 (CD158d) genotype influences expression and function in NK cells. J. Immunol. 171: 1768-1774.
16. Gomez-Lozano, N., R. de Pablo, S. Puente, and C. Vilches. 2003. Recognition of HLA-G by the NK cell receptor KIR2DL4 is not essential for human reproduction. Eur. J. Immunol. 33: 639-644.
17. Rajagopalan, S., and E. O. Long. 1999. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. J. Exp. Med. 189: 1093-1100.
18. Colonna, M., J. Samaridis, M. Cella, L. Angman, R. L. Allen, C. A. O'Callaghan, R. Dunbar, G. S. Ogg, V. Cerundolo, and A. Rolink. 1998. Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J. Immunol. 160: 3096-3100.
19. Avril, T., A. C. Jarousseau, H. Watier, J. Boucraut, P. Le Bouteiller, P. Bardos, and G. Thibault. 1999. Trophoblast cell line resistance to NK lysis mainly involves an HLA class I-independent mechanism. J. Immunol. 162: 5902-5909.
20. Bainbridge, D., S. Ellis, P. Le Bouteiller, and I. Sargent. 2001. HLA-G remains a mystery. Trends Immunol. 22: 548-552.
21. Mandelboim, O., H. T. Reyburn, M. Vales-Gomez, L. Pazmany, M. Colonna, G. Borsellino, and J. L. Strominger. 1996. Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules. J. Exp. Med. 184: 913-922.
22. LeMaoult, J., M. Le Discorde, N. Rouas-Freiss, P. Moreau, C. Menier, J. McCluskey, and E. D. Carosella. 2003. Biology and functions of human leukocyte antigen-G in health and sickness. Tissue Antigens 62: 273-284.
23. Carosella, E. D., J. Dausset, and M. Kirszenbaum. 1996. HLA-G revisited. Immunol. Today 17: 407-409.
24. Dong, Y., J. Lieskovska, D. Kedrin, S. Porcelli, O. Mandelboim, and Y. Bushkin. 2003. Soluble nonclassical HLA generated by the metalloproteinase pathway. Hum. Immunol. 64: 802-810.
25. 2m free nonclassical HLA-G molecules also binds to free heavy chains of classical HLA class I antigens present on activated lymphocytes. Hum. Immunol. 65: 157-162.
26. Gonen-Gross, T., H. Achdout, R. Gazit, J. Hanna, S. Mizrahi, G. Markel, D. Goldman-Wohl, S. Yagel, V. Horejsi, O. Levy, et al. 2003. Complexes of HLA-G protein on the cell surface are important for leukocyte Ig-like receptor-1 function. J. Immunol. 171: 1343-1351.
27. Gonen-Gross, T., R. Gazit, H. Achdout, J. Hanna, S. Mizrahi, G. Markel, V. Horejsi, and O. Mandelboim. 2003. Special organization of the HLA-G protein on the cell surface. Hum. Immunol. 64: 1011-1016.
28. Boyson, J. E., R. Erskine, M. C. Whitman, M. Chiu, J. M. Lau, L. A. Koopman, M. M. Valter, P. Angelisova, V. Horejsi, and J. L. Strominger. 2002. Disulfide bond-mediated dimerization of HLA-G on the cell surface. Proc. Natl. Acad. Sci. USA 99: 16180-16185.
29. Sernee, M. F., H. L. Ploegh, and D. J. Schust. 1998. Why certain antibodies cross-react with HLA-A and HLA-G: epitope mapping of two common MHC class I reagents. Mol. Immunol. 35: 177-188.
30. 2-Microglobulin-free HLA class I heavy chain epitope mimicry by monoclonal antibody HC-10-specific peptide. J. Immunol. 171: 1918-1926.
31. Stam, N. J., H. Spits, and H. L. Ploegh. 1986. Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products. J. Immunol. 137: 2299-2306.
32. LIR1 and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells. Eur. J. Immunol. 29: 277-283.
33. Mandelboim, O., N. Lieberman, M. Lev, L. Paul, T. I. Arnon, Y. Bushkin, D. M. Davis, J. L. Strominger, J. W. Yewdell, and A. Porgador. 2001. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 409: 1055-1060.
34. Blaschitz, A., H. Hutter, V. Leitner, S. Pilz, R. Wintersteiger, G. Dohr, and P. Sedlmayr. 2000. Reaction patterns of monoclonal antibodies to HLA-G in human tissues and on cell lines: a comparative study. Hum. Immunol. 61: 1074-1085.
35. Kohler, P. O., and W. E. Bridson. 1971. Isolation of hormone-producing clonal lines of human choriocarcinoma. J. Clin. Endocrinol. Metab. 32: 683-687.
36. 2-microglobulin leads to the accumulation of a substantial pool of inactive class I MHC heavy chains on the cell surface. Cell 65: 611-620.
37. Polakova, K., J. R. Bennink, J. W. Yewdell, M. Bystricka, E. Bandzuchova, and G. Russ. 2003. Mild acid treatment induces cross-reactivity of 4H84 monoclonal antibody specific to nonclassical HLA-G antigen with classical HLA class I molecules. Hum. Immunol. 64: 256-264.
38. Willcox, B. E., L. M. Thomas, and P. J. Bjorkman. 2003. Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor. Nat. Immunol. 4: 913-919.
39. 2-microglobulin-free HLA class I α-chains on activated T cells requires internalization of HLA class I heterodimers. Immunology 88: 104-109.
40. Chumbley, G., A. King, N. Holmes, and Y. W. Loke. 1993. In situ hybridization and Northern blot demonstration of HLA-G mRNA in human trophoblast populations by locus-specific oligonucleotide. Hum. Immunol. 37: 17-22.
41. Riteau, B., C. Menier, I. Khalil-Daher, C. Sedlik, J. Dausset, N. Rouas-Freiss, and E. D. Carosella. 1999. HLA-G inhibits the allogeneic proliferative response. J. Reprod. Immunol. 43: 203-211.
42. Perez-Villar, J. J., I. Melero, F. Navarro, M. Carretero, T. Bellon, M. Llano, M. Colonna, D. E. Geraghty, and M. Lopez-Botet. 1997. The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1. J. Immunol. 158: 5736-5743.
43. Ponte, M., C. Cantoni, R. Biassoni, A. Tradori-Cappai, G. Bentivoglio, C. Vitale, S. Bertone, A. Moretta, L. Moretta, and M. C. Mingari. 1999. Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor. Proc. Natl. Acad. Sci. USA 96: 5674-5679.
44. Pazmany, L., O. Mandelboim, M. Vales-Gomez, D. M. Davis, H. T. Reyburn, and J. L. Strominger. 1996. Protection from natural killer cell-mediated lysis by HLA-G expression on target cells. Science 274: 792-795.
45. Munz, C., N. Holmes, A. King, Y. W. Loke, M. Colonna, H. Schild, and H. G. Rammensee. 1997. Human histocompatibility leukocyte antigen (HLA)-G molecules inhibit NKAT3 expressing natural killer cells. J. Exp. Med. 185: 385-391.
46. Diehl, M., C. Munz, W. Keilholz, S. Stevanovic, N. Holmes, Y. W. Loke, and H. G. Rammensee. 1996. Nonclassical HLA-G molecules are classical peptide presenters. Curr. Biol. 6: 305-314.
47. Loke, Y. W., A. King, T. Burrows, L. Gardner, M. Bowen, S. Hiby, S. Howlett, N. Holmes, and D. Jacobs. 1997. Evaluation of trophoblast HLA-G antigen with a specific monoclonal antibody. Tissue Antigens 50: 135-146.
48. Clements, C. S., L. Kjer-Nielsen, L. Kostenko, H. L. Hoare, M. A. Dunstone, E. Moses, K. Freed, A. G. Brooks, J. Rossjohn, and J. McCluskey. 2005. Crystal structure of HLA-G: a nonclassical MHC class I molecule expressed at the fetal-maternal interface. Proc. Natl. Acad. Sci. USA 102: 3360-3365.
49. Reveille, J. D., E. J. Ball, and M. A. Khan. 2001. HLA-B27 and genetic predisposing factors in spondyloarthropathies. Curr. Opin. Rheumatol. 13: 265-272.
50. Shiroishi, M., K. Tsumoto, K. Amano, Y. Shirakihara, M. Colonna, V. M. Braud, D. S. Allan, A. Makadzange, S. Rowland-Jones, B. Willcox, et al. 2003. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Proc. Natl. Acad. Sci. USA 100: 8856-8861.
51. Allen, R. L., T. Raine, A. Haude, J. Trowsdale, and M. J. Wilson. 2001. Leukocyte receptor complex-encoded immunomodulatory receptors show differing specificity for alternative HLA-B27 structures. J. Immunol. 167: 5543-5547.
52. Khalil-Daher, I., B. Riteau, C. Menier, C. Sedlik, P. Paul, J. Dausset, E. D. Carosella, and N. Rouas-Freiss. 1999. Role of HLA-G versus HLA-E on NK function: HLA-G is able to inhibit NK cytolysis by itself. J. Reprod. Immunol. 43: 175-182.
53. Riteau, B., C. Menier, I. Khalil-Daher, S. Martinozzi, M. Pla, J. Dausset, E. D. Carosella, and N. Rouas-Freiss. 2001. HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibition. Int. Immunol. 13: 193-201.
54. Le Gal, F. A., B. Riteau, C. Sedlik, I. Khalil-Daher, C. Menier, J. Dausset, J. G. Guillet, E. D. Carosella, and N. Rouas-Freiss. 1999. HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes. Int. Immunol. 11: 1351-1356.
55. Della Chiesa, M., M. Vitale, S. Carlomagno, G. Ferlazzo, L. Moretta, and A. Moretta. 2003. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors. Eur. J. Immunol. 33: 1657-1666.
56. Ciccone, E., D. Pende, L. Nanni, C. Di Donato, O. Viale, A. Beretta, M. Vitale, S. Sivori, A. Moretta, and L. Moretta. 1995. General role of HLA class I molecules in the protection of target cells from lysis by natural killer cells: evidence that the free heavy chains of class I molecules are not sufficient to mediate the protective effect. Int. Immunol. 7: 393-400.
57. Hauser, T. A., A. M. Malyguine, and J. R. Dawson. 1998. Conformation dependence of MHC class I in the modulation of target cell sensitivity to natural killing. Hum. Immunol. 59: 71-76.
58. 2m-free MHC class I molecules induced on activated T cells. Cell. Immunol. 142: 103-113.
59. 2-microglobulin-free HLA class I heavy chain serum levels in the course of immune responses to viral antigens and to mismatched HLA antigens. Tissue Antigens 55: 333-341.
60. + cells and inhibit cytotoxic T cell activity through CD8 ligation. Eur. J. Immunol. 33: 125-134.
61. King, A., S. E. Hiby, S. Verma, T. Burrows, L. Gardner, and Y. W. Loke. 1997. Uterine NK cells and trophoblast HLA class I molecules. Am. J. Reprod. Immunol. 37: 459-462.
62. Bird, L. A., C. A. Peh, S. Kollnberger, T. Elliott, A. J. McMichael, and P. Bowness. 2003. Lymphoblastoid cells express HLA-B27 homodimers both intracellularly and at the cell surface following endosomal recycling. Eur. J. Immunol. 33: 748-759.
63. Dangoria, N. S., M. L. DeLay, D. J. Kingsbury, J. P. Mear, B. Uchanska-Ziegler, A. Ziegler, and R. A. Colbert. 2002. HLA-B27 misfolding is associated with aberrant intermolecular disulfide bond formation (dimerization) in the endoplasmic reticulum. J. Biol. Chem. 277: 23459-23468.
64. Antoniou, A. N., S. Ford, J. D. Taurog, G. W. Butcher, and S. J. Powis. 2004. Formation of HLA-B27 homodimers and their relationship to assembly kinetics. J. Biol Chem. 279: 8895-8902.
65. Tran, T. M., N. Satumtira, M. L. Dorris, E. May, A. Wang, E. Furuta, and J. D. Taurog. 2004. HLA-B27 in transgenic rats forms disulfide-linked heavy chain oligomers and multimers that bind to the chaperone BiP. J. Immunol. 172: 5110-5119.
66. Carosella, E. D., and J. Dausset. 2003. Progress of HLA-G in cancer. Semin. Cancer Biol. 13: 315-316.